LLY
914.51
+0.93%↑
UNH
577.15
-0.55%↓
NVO
134.78
+2.03%↑
JNJ
164.87
-0.88%↓
ABBV
193.46
+0.25%↑
LLY
914.51
+0.93%↑
UNH
577.15
-0.55%↓
NVO
134.78
+2.03%↑
JNJ
164.87
-0.88%↓
ABBV
193.46
+0.25%↑
LLY
914.51
+0.93%↑
UNH
577.15
-0.55%↓
NVO
134.78
+2.03%↑
JNJ
164.87
-0.88%↓
ABBV
193.46
+0.25%↑
LLY
914.51
+0.93%↑
UNH
577.15
-0.55%↓
NVO
134.78
+2.03%↑
JNJ
164.87
-0.88%↓
ABBV
193.46
+0.25%↑
LLY
914.51
+0.93%↑
UNH
577.15
-0.55%↓
NVO
134.78
+2.03%↑
JNJ
164.87
-0.88%↓
ABBV
193.46
+0.25%↑
Resumen
Variación precio
24h
Actual
Mínimo
Máximo
Recomendaciones | Comprar |
---|---|
Estimación a 12 meses | +532.91 upside |
AcelRx Pharmaceuticals Inc Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
19 sept 2024, 23:50 UTC
Stocks to Watch: Nike, FedEx, Alliance Entertainment Holding, Arq
DJ
Leer
19 sept 2024, 20:59 UTC
FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue in 1Q -- Update
DJ
Leer
19 sept 2024, 20:41 UTC
Nike CEO John Donahoe to Retire
DJ
Leer
19 sept 2024, 20:40 UTC
FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue in 1Q
DJ
Leer
19 sept 2024, 23:24 UTC
Sims U.S. Business Shines, But Asia Headwinds Remain -- Market Talk
DJ
Leer
19 sept 2024, 23:01 UTC
U.K. Consumers Turn Notably Gloomier, Survey Says
DJ
Leer
19 sept 2024, 22:21 UTC
FedEx Warns of Continued, Worsening Headwinds in 2Q -- Market Talk
DJ
Leer
19 sept 2024, 22:17 UTC
Why Fed Rate Cuts Are Hurting Treasury Bonds -- Barrons.com
DJ
Leer
19 sept 2024, 22:13 UTC
FedEx Counts on Price Hikes to Help Hurting Top and Bottom Lines -- Market Talk
DJ
Leer
19 sept 2024, 22:13 UTC
Global Equities Roundup: Market Talk
DJ
Leer
19 sept 2024, 22:06 UTC
FedEx Stock Is Down. Earnings Show Why The Fed Cut Rates. -- Barrons.com
DJ
Leer
19 sept 2024, 21:46 UTC
FedEx Cuts Full-Year Outlook After Posting Lower Profit, Revenue -- Update
DJ
Leer
19 sept 2024, 21:06 UTC
FedEx Stock Slumps. It Wasn't Just the Earnings That Were Bad. -- Barrons.com
DJ
Leer
19 sept 2024, 20:50 UTC
Tech, Media & Telecom Roundup: Market Talk
DJ
Leer
19 sept 2024, 20:50 UTC
Financial Services Roundup: Market Talk
DJ
Leer
19 sept 2024, 20:50 UTC
Auto & Transport Roundup: Market Talk
DJ
Leer
19 sept 2024, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Leer
19 sept 2024, 20:42 UTC
FedEx Stock Skids, Set To Snap Support As Q1 Results Disappoint -- IBD
DJ
Leer
19 sept 2024, 20:39 UTC
Dow, S&P 500 Hit Records After Rate Cut -- WSJ
DJ
Leer
19 sept 2024, 20:12 UTC
FedEx Unable to Provide FY25 EPS or Effective Tax Rate Outlook on GAAP Basis >FDX
DJ
Leer
19 sept 2024, 20:12 UTC
FedEx Cash On-Hand as of Aug 31 Was $5.9 B >FDX
DJ
Leer
19 sept 2024, 20:11 UTC
FedEx Stock Slumps. It Wasn't Just the Earnings That Were Bad. -- Barrons.com
DJ
Leer
19 sept 2024, 20:11 UTC
FedEx: 'Committed to Our Plan to Return $3.8 B to Stockholders This Fiscal Yr' >FDX
DJ
Leer
19 sept 2024, 20:11 UTC
FedEx Expects Recent Pricing Actions to Help Offset Weaker-Than-Expected Demand Trends >FDX
DJ
Leer
19 sept 2024, 20:10 UTC
Dow Crosses 42000, Hits Record in Post-Fed Rally -- WSJ
DJ
Leer
19 sept 2024, 20:10 UTC
FedEx Reaffirms FY25 Capital Spending of $5.2 B >FDX
DJ
Leer
19 sept 2024, 20:10 UTC
FedEx Reaffirms Permanent Cost Reductions From DRIVE Transformation Program of $2.2 B >FDX
DJ
Leer
19 sept 2024, 20:10 UTC
FedEx Had Previously Forecast of Low-To-Mid Single Digit Percentage Increase in Rev for FY25>FDX
DJ
Leer
19 sept 2024, 20:09 UTC
FedEx Sees Low Single-Digit Percentage Rev Growth Rate Yr Over Yr for FY25>FDX
DJ
Leer
19 sept 2024, 20:09 UTC
FedEx Sees FY25 EPS $20 to $21 After Also Excluding Costs Related to Business Optimization Initiatives >FDX
DJ
Leer
Comparación entre iguales
Cambio de precio
AcelRx Pharmaceuticals Inc Esperado
Precio Objetivo
By TipRanks
Estimación a 12 meses
Media 5 USD 532.91%
Máximo 5 USD
Mínimo 5 USD
De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AcelRx Pharmaceuticals Inc Dist en los últimos 3 meses.
Consenso
By TipRanks
Comprar
1 ratings
1
Comprar
0
Mantener
0
Vender
De acuerdo con 1 analistas que ofrecen calificaciones bursátiles a para AcelRx Pharmaceuticals Inc Dist en los últimos 3 meses.